High cholesterol and lipid metabolism disorder: causes, risk & modern treatment
At a glance
FrequencyElevated LDL cholesterol affects a large proportion of adults in Germany — many are unaware of it
Why it mattersElevated LDL cholesterol is one of the most important risk factors for heart attack and stroke
Key valueLDL cholesterol (low-density lipoprotein) — the lower, the better for the cardiovascular risk
TreatmentLifestyle change + statins as first-line therapy, if needed ezetimibe, bempedoic acid, PCSK9 inhibitors
GuidelineESC/EAS 2025 Focused Update on dyslipidaemia
ICD-10E78 (disorders of lipoprotein metabolism)
1. What is high cholesterol?
Cholesterol is a vital component of every body cell. The body produces most of it itself; some is taken in through food. It becomes a problem when LDL cholesterol (colloquially: bad cholesterol) is permanently elevated — because LDL deposits in the vessel walls and promotes atherosclerosis (vascular calcification).¹
Elevated LDL cholesterol is one of the most important modifiable risk factors for heart attack, stroke and other cardiovascular diseases. The evidence for this is clear according to current knowledge: the lower the LDL cholesterol, the lower the risk — the ESC/EAS guideline (Focused Update 2025) frames it as a basic principle.¹
Very treatable — even without symptoms
High cholesterol can usually be treated well — through a combination of lifestyle change and medications. Because the condition causes no symptoms for a long time, regular monitoring of the values is especially important.
2. LDL, HDL, triglycerides — what do the values mean?
- LDL cholesterol: transports cholesterol into the vessels and deposits it there. Elevated values promote atherosclerosis. The most important target value of treatment.¹
- HDL cholesterol: transports excess cholesterol back to the liver (a protective function). Low values are considered a risk factor. According to current knowledge, however, there is no medication that lowers the cardiovascular risk by raising HDL.
- Triglycerides: blood fats that rise with excess energy intake (especially sugar, alcohol, excess weight). Strongly elevated triglycerides can increase the cardiovascular risk and in rare cases trigger an acute pancreatitis.
- Total cholesterol: the sum of LDL, HDL and VLDL. Often measured, but less informative than LDL cholesterol alone.
- Lipoprotein(a) (Lp(a)): a genetically determined risk factor that was included as a risk modifier in the ESC/EAS update 2025. It is usually measured once in a lifetime. It can currently barely be influenced by medication — new therapies are in development.
3. Causes and risk factors
- Diet: a high proportion of saturated fatty acids (fatty meat, sausage, cheese, butter, coconut fat) and trans fatty acids (fried food, baked goods, ready-made products) can raise LDL.
- Lack of exercise: a sedentary lifestyle.
- Excess weight: obesity usually raises LDL and triglycerides and lowers HDL.
- Genetics: familial hypercholesterolaemia (FH) is a common genetic condition that leads to strongly elevated LDL values already at a young age. It is often not recognized (see the separate section below).
- Other conditions: hypothyroidism, chronic kidney disease, type 2 diabetes, liver diseases.
- Medications: certain medications can affect lipid metabolism (e.g. cortisone, beta blockers, thiazides, immunosuppressants).
4. Symptoms
High cholesterol usually causes no symptoms
That is why it is often only discovered when a cardiovascular disease has already occurred (heart attack, stroke, peripheral arterial disease). Regular blood tests are therefore important — especially with risk factors or a positive family history.¹
With very strongly elevated values (especially with familial hypercholesterolaemia), visible signs can appear:
- Xanthomas: cholesterol deposits in tendons or under the skin
- Xanthelasmas: yellowish deposits on the eyelids
- Arcus lipoides: a whitish ring around the cornea
These signs are rare but diagnostically telling — they should prompt consideration of a familial form.
5. Diagnosis and risk assessment
- Lipid profile: total cholesterol, LDL, HDL, triglycerides — usually fasting or non-fasting (the results are comparable for most values). LDL is the decisive target value.
- Risk assessment: the ESC/EAS guideline recommends an individual risk assessment — in the 2025 update with SCORE2 (for ages 40–69) and SCORE2-OP (for ages 70–89). The overall risk determines the LDL target values and the treatment intensity.¹
- LDL target values (ESC/EAS 2025): depend on the individual cardiovascular risk. The higher the risk, the lower the target value. For people with existing cardiovascular disease or a very high risk, the lowest target values usually apply.¹
- Lipoprotein(a): recommended as a risk modifier in the 2025 update — it should usually be measured once in a lifetime.
More: Preparing for a doctor's appointment, Understanding your blood values.